PCM
PFE icon

Perritt Capital Management’s Pfizer PFE Stock Holding History

Perritt Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,717
Closed -$451K – 230
2025
Q3 		$451K Buy
17,717
+92
+0.5% +$2.27K 0.21% 97
2025
Q2 		$427K Sell
17,625
-323
-2% -$7.53K 0.22% 97
2025
Q1 		$455K Sell
17,948
-1,990
-10% -$52.1K 0.25% 86
2024
Q4 		$529K Buy
19,938
+522
+3% +$14.2K 0.27% 88
2024
Q3 		$562K Buy
19,416
+237
+1% +$6.91K 0.29% 82
2024
Q2 		$537K Buy
19,179
+2,896
+18% +$79.7K 0.29% 81
2024
Q1 		$452K Buy
16,283
+1,284
+9% +$35.6K 0.24% 98
2023
Q4 		$432K Sell
14,999
-4,522
-23% -$137K 0.24% 97
2023
Q3 		$648K Hold
19,521
– – 0.37% 66
2023
Q2 		$716K Hold
19,521
– – 0.39% 60
2023
Q1 		$796K Sell
19,521
-1,290
-6% -$55.7K 0.44% 53
2022
Q4 		$1.07M Sell
20,811
-1,048
-5% -$50.2K 0.61% 35
2022
Q3 		$957K Sell
21,859
-385
-2% -$18.7K 0.61% 35
2022
Q2 		$1.17M Sell
22,244
-300
-1% -$15.3K 0.71% 22
2022
Q1 		$1.17M Hold
22,544
– – 0.63% 29
2021
Q4 		$1.33M Buy
22,544
+60
+0.3% +$2.97K 0.69% 24
2021
Q3 		$967K Sell
22,484
-200
-0.9% -$8.86K 0.53% 42
2021
Q2 		$888K Buy
22,684
+1,856
+9% +$72.2K 0.46% 52
2021
Q1 		$755K Buy
20,828
+1,535
+8% +$54.5K 0.41% 60
2020
Q4 		$710K Buy
19,293
+1,054
+6% +$38.7K 0.43% 59
2020
Q3 		$635K Buy
18,239
+312
+2% +$10.9K 0.47% 60
2020
Q2 		$556K Buy
17,927
+360
+2% +$12.2K 0.42% 74
2020
Q1 		$544K Hold
17,567
– – 0.44% 69
2019
Q4 		$653K Sell
17,567
-128
-0.7% -$4.56K 0.31% 95
2019
Q3 		$603K Hold
17,695
– – 0.26% 112
2019
Q2 		$727K Sell
17,695
-46
-0.3% -$1.83K 0.29% 106
2019
Q1 		$715K Hold
17,741
– – 0.27% 112
2018
Q4 		$735K Hold
17,741
– – 0.28% 99
2018
Q3 		$742K Hold
17,741
– – 0.22% 127
2018
Q2 		$611K Hold
17,741
– – 0.18% 138
2018
Q1 		$598K Sell
17,741
-58
-0.3% -$1.99K 0.17% 137
2017
Q4 		$612K Buy
17,799
+110
+0.6% +$3.75K 0.17% 153
2017
Q3 		$599K Hold
17,689
– – 0.16% 158
2017
Q2 		$564K Sell
17,689
-186
-1% -$5.87K 0.15% 161
2017
Q1 		$580K Buy
17,875
+383
+2% +$12.1K 0.15% 147
2016
Q4 		$539K Sell
17,492
-828
-5% -$25.3K 0.13% 147
2016
Q3 		$589K Sell
18,320
-289
-2% -$9.66K 0.15% 144
2016
Q2 		$622K Hold
18,609
– – 0.16% 134
2016
Q1 		$523K Buy
18,609
+659
+4% +$18.8K 0.13% 153
2015
Q4 		$550K Hold
17,950
– – 0.12% 155
2015
Q3 		$535K Sell
17,950
-211
-1% -$6.76K 0.11% 158
2015
Q2 		$578K Sell
18,161
-68
-0.4% -$2.22K 0.1% 175
2015
Q1 		$602K Sell
18,229
-247
-1% -$7.85K 0.11% 177
2014
Q4 		$546K Hold
18,476
– – 0.1% 180
2014
Q3 		$518K Sell
18,476
-40
-0.2% -$1.12K 0.1% 194
2014
Q2 		$521K Sell
18,516
-1,945
-10% -$55.4K 0.09% 217
2014
Q1 		$624K Sell
20,461
-131
-0.6% -$3.91K 0.1% 214
2013
Q4 		$598K Sell
20,592
-72
-0.3% -$2.1K 0.1% 190
2013
Q3 		$563K Hold
20,664
– – 0.11% 162
2013
Q2 		$549K Buy
+20,664
New +$571K 0.12% 155

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perritt Capital Management's PFE Position: Q4 2025 in Review

Perritt Capital Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 17,717 shares — an estimated $451K sold.

Perritt Capital Management first reported a position in PFE in Q2 2013 and held it in 50 quarters. The position peaked at $1.33M in Q4 2021. 2,907 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Perritt Capital Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Perritt Capital Management sold 17,717 Pfizer shares in Q4 2025, an estimated $451K.
  • Perritt Capital Management first reported a position in Pfizer in Q2 2013 and held it in 50 quarters.
  • Perritt Capital Management's Pfizer position peaked at $1.33M in Q4 2021.
  • 2,907 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Perritt Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.